Profile data is unavailable for this security.
About the company
INIFY Laboratories AB is a Sweden-based medical research company that provides cancer diagnostics through laboratory services within pathology. The Company uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The Company origins from ContextVision.
- Revenue in NOK (TTM)21.22m
- Net income in NOK-64.70m
- Incorporated2021
- Employees34.00
- LocationINIFY Laboratories ABScheeles vag 3SOLNA 171 65SwedenSWE
- Phone+46 8267330
- Websitehttps://www.inify.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| iZafe Group AB | 6.31m | -17.57m | 171.45m | 10.00 | -- | 13.95 | -- | 27.17 | -0.0497 | -0.0497 | 0.0178 | 0.0315 | 0.2002 | 4.03 | 8.65 | 599,100.00 | -55.71 | -66.81 | -91.50 | -83.32 | -74.75 | -303.52 | -278.35 | -762.55 | 0.47 | -2,397.57 | 0.0054 | -- | -24.68 | -7.62 | 18.69 | -- | -- | -- |
| Subgen AI AB | 0.00 | -67.60m | 175.11m | 15.00 | -- | -- | -- | -- | -544.10 | -544.10 | 0.00 | -25.11 | 0.00 | -- | -- | 0.00 | -188.83 | -- | -403.12 | -- | -- | -- | -- | -- | -- | -4.46 | -- | -- | -100.00 | -- | 16.86 | -- | -- | -- |
| Boule Diagnostics AB | 515.76m | -3.69m | 175.90m | 187.00 | -- | 0.9963 | 9.94 | 0.3411 | -0.10 | -0.10 | 12.63 | 4.32 | 0.9926 | 4.68 | 3.50 | 2,618,182.00 | -0.7096 | -7.78 | -1.35 | -11.85 | 43.65 | 43.53 | -0.7149 | -9.10 | 0.8039 | 2.96 | 0.5717 | -- | -12.31 | 4.11 | 98.72 | -- | -5.26 | -- |
| Kdventures AB | 1.76m | -204.21m | 186.86m | 8.00 | -- | 0.0856 | -- | 106.15 | -0.5849 | -0.5849 | 0.005 | 3.16 | 0.0015 | -- | 0.4858 | -- | -16.82 | -1.95 | -16.98 | -2.03 | -- | -- | -11,601.14 | -1,139.53 | -- | -0.7754 | 0.0011 | -- | -9.09 | -8.82 | -2,292.98 | -- | -- | -- |
| Micropos Medical AB (publ) | 8.51m | -22.89m | 192.06m | 9.00 | -- | -- | -- | 22.57 | -0.1398 | -0.1398 | 0.0514 | -- | -- | -- | -- | -- | -- | -83.62 | -- | -110.96 | 120.03 | 94.59 | -268.99 | -558.00 | -- | -99.12 | -- | -- | 112.49 | 17.01 | 0.7589 | -- | -16.83 | -- |
| Clinical Laserthermia Systems AB | 18.42m | -43.84m | 196.64m | 16.00 | -- | 2.68 | -- | 10.67 | -1.55 | -1.55 | 0.6504 | 2.24 | 0.2256 | 2.61 | 4.86 | -- | -54.24 | -97.83 | -60.76 | -163.00 | -55.85 | -331.65 | -240.44 | -577.10 | 2.64 | -2.20 | 0.00 | -- | -6.90 | 67.36 | 12.62 | -- | 38.66 | -- |
| SciBase Holding AB (publ) | 38.54m | -95.22m | 218.16m | 34.00 | -- | 3.71 | -- | 5.66 | -0.2487 | -0.2487 | 0.0978 | 0.0674 | 0.6648 | 1.29 | 3.23 | 1,143,250.00 | -164.26 | -75.65 | -244.76 | -101.01 | 66.04 | 65.08 | -247.08 | -256.98 | 2.07 | -11.75 | 0.00 | -- | 27.79 | 26.21 | -9.97 | -- | -20.49 | -- |
| BrainCool AB (publ) | 38.15m | -39.03m | 227.54m | 17.00 | -- | 0.7884 | -- | 5.96 | -0.1427 | -0.1427 | 0.1395 | 0.6938 | 0.2044 | 1.03 | 1.37 | 2,130,235.00 | -20.91 | -33.76 | -23.03 | -42.19 | 26.29 | 40.37 | -102.31 | -179.58 | 4.88 | -8.62 | -- | -- | -9.38 | 38.79 | 15.88 | -- | -2.87 | -- |
| ContextVision AB | 116.11m | 802.29k | 231.81m | 43.00 | 276.29 | 2.39 | 28.21 | 2.00 | 0.0108 | 0.0108 | 1.53 | 1.25 | 0.8645 | 2.70 | 3.54 | 2,700,165.00 | 0.5974 | 22.42 | 0.7498 | 32.76 | 97.37 | 98.40 | 0.691 | 21.46 | 4.23 | -- | 0.1202 | -- | -15.61 | 3.08 | -96.81 | -53.90 | -13.09 | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -37.48m | 231.94m | 21.00 | -- | 1.21 | -- | -- | -4.03 | -4.03 | 0.00 | 15.08 | 0.00 | -- | -- | 0.00 | -19.97 | -- | -24.07 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 80.11 | -- | -1.65 | -- |
| Integrum AB | 102.18m | -31.45m | 238.54m | 37.00 | -- | 1.20 | -- | 2.33 | -1.37 | -1.37 | 4.50 | 7.26 | 0.5253 | 0.828 | 3.40 | 2,487,052.00 | -16.17 | -3.58 | -17.87 | -4.08 | 75.61 | 83.88 | -30.78 | -6.47 | 1.88 | -- | 0.025 | -- | -12.50 | 27.78 | -864.22 | -- | 103.14 | -- |
| INIFY Laboratories AB | 21.22m | -64.70m | 324.43m | 34.00 | -- | 2.35 | -- | 15.29 | -1.13 | -1.13 | 0.3664 | 1.70 | 0.1928 | 2.96 | 3.12 | 848,737.60 | -58.78 | -- | -58.78 | -- | 85.20 | -- | -304.93 | -- | -- | -- | 0.00 | -- | 1,000.67 | -- | 3.15 | -- | -- | -- |
| Acarix AB | 7.75m | -50.66m | 336.07m | 8.00 | -- | 8.67 | -- | 43.35 | -0.0427 | -0.0427 | 0.0065 | 0.0328 | 0.114 | 0.1658 | 3.37 | -- | -74.50 | -80.03 | -84.46 | -94.19 | 84.74 | 83.62 | -653.38 | -1,091.79 | 3.45 | -623.52 | -- | -- | 18.69 | 27.67 | 27.34 | -- | -- | -- |
| Ortoma AB | 81.31m | -7.92m | 438.42m | 10.00 | -- | 2.64 | 79.70 | 5.39 | -0.2027 | -0.2027 | 2.08 | 4.45 | 0.4243 | 3.95 | 39.13 | 7,530,537.00 | -4.13 | -9.37 | -4.45 | -10.43 | 41.26 | 158.24 | -9.74 | -78.90 | 3.02 | -- | 0.00 | -- | 28.77 | -- | 46.83 | -- | -0.5751 | -- |
| Mentice AB | 289.15m | -45.62m | 454.80m | 121.00 | -- | 3.43 | -- | 1.57 | -1.68 | -1.68 | 10.52 | 4.48 | 0.9663 | 1.60 | 3.94 | 2,095,328.00 | -15.25 | -6.64 | -31.60 | -11.91 | 90.40 | 84.80 | -15.78 | -8.53 | 0.845 | -30.10 | 0.116 | -- | 6.11 | 14.22 | -553.89 | -- | 32.86 | -- |
Data as of Mar 02 2026. Currency figures normalised to INIFY Laboratories AB's reporting currency: Norwegian Krone NOK
0.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aktia Bank Plc (Investment Management)as of 31 Oct 2025 | 301.30k | 0.38% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
